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Objective: Adiponectin is a protein secreted by adipose tissue and involved in inﬂammatory process as
well as in metabolic regulation. The aim of this study was to examine the response of plasma adiponectin
to cardiac surgery in children with congenital defects to determine whether its measurement is associated
to the response to injury.
Design and methods: Twenty-ﬁve pediatric patients undergoing heart surgery for correction of congen-
ital defects were studied. Adiponectin plasma levels, obtained pre- and three times postoperatively, were de-
termined by dedicated ELISA. Brain natriuretic peptide (BNP) plasma levels were also determined.
Results: Adiponectin levels are highest in the ﬁrst month of life (p=0.004 newborns vs. children) with a
progressive fall in the next few years. After surgery, adiponectin increased slowly over a 1-month period, fol-
lowing an initial decrease in the ﬁrst 3 days.Conclusions: Adiponectin could be involved in the acute response to injury although further investiga-
tion into the relationship between adiponectin, glucose regulation and inﬂammatory process is necessary
to examine the issue of the adiponectin decrease after surgery from a more integrated prospective.© 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.Introduction
Metabolic responses to surgical injury are partly regulated by two
processes, the acute phase and the glycemic response. During the ﬁrst
phase, Interleukin (IL)-6 stimulates the liver to produce proteins,
such as C-reactive protein (CRP), proportionally to the dimension of
the injury and typically reaching a peak within 72 h [1]. Soon after,
the glycemic response occurs, resulting in hyperglycemia propor-
tional to the extent of the injury [2]. Regarding cardiac surgery,
in pediatric patients cardiopulmonary by-pass induces a systemic
inﬂammatory response, involving CRP [1,2] and IL-6 [3] and causes
peri-operative hyperglycemia [4]. In neonates, hormonal and meta-
bolic responses are distinct and more extreme than in adult patients
and are associated with a high hospital mortality rate [1].
At the present, few data are available on interrelationship between
inﬂammatory (acute phase) and glycemic metabolic injury-response
parameters in association with injury severity and outcome in the pedi-
atric cardiosurgery setting. Adiponectin, an adipocyte-derived protein,
exerts anti-inﬂammatory and insulin-sensitizing actions [5]. In childhood,hysiology, Laboratory of Car-
Moruzzi, 1 56100 Pisa, Italy.
ociety of Clinical Chemists. Publishethe use of adiponectin as a biomarker for insulin sensitivity and/or as a
risk factor for cardiovascular disease is gaining support [6].
The aim of this preliminary studywas to check if plasma adiponectin
is modulated by cardiac surgery in order to explore the possibility to
use this protein as biomarker of the post-surgery response. For this,
adiponectin levels were measured in pediatric patients before and
after cardiac surgery performed to correct congenital defects up to 1
month, a time largely higher of the post-cardiac recovery. Few data
are available on this issue [7], especially in children, so these results
will be a starting point to plan a larger study devoted to investigate
the role of adiponectin in the inﬂammatory/metabolic response after
cardiosurgery in pediatric patients. Due to the relationship of natriuretic
peptide on adiponectin production [8], plasma levels of brain natriuretic
peptide (BNP) were also determined in the same patients at baseline.Material and methods
We studied a group of 25 neonates and infants admitted to the Pedi-
atric Cardiac Surgery Unit of Heart Hospital, Fondazione Monasterio,
Massa, Italy (14 males, 64±72 months, mean±SD) with various cardi-
ac defects (2 aortic coarctation, 4 atrial septal defects, 1 congenital
corrected transposition, 2 cardiomyopathies, 2 total anomalous pulmo-
nary venous return, 3 transposition of the great arteries, 3 tetralogy of
Fallot, 4 univentricular heart, and 4 ventricular septal defects).d by Elsevier Inc. All rights reserved.
Fig. 2. Relationship between adiponectin and BNP at baseline: the values of the plasma
levels after natural logarithmic transformation are reported (Spearman's rho=0.628,
p=0.002).
1511C. Caselli et al. / Clinical Biochemistry 45 (2012) 1510–1512Children were evaluated before surgery by physical examination,
standard 12-lead electrocardiogram, and chest X-ray. Diagnosis of
congenital heart disease (CHD) was made by means of a standard
trans-thoracic echocardiography according to international guide-
lines [9]. In the postoperative period, medical hemodynamic man-
agement involved epinephrine (0.005–0.15 μg/kg/min), milrinone
(0.5–0.75 μg kg/min), dopamine (5–20 μg /kg/min), and noradrena-
line (0.05–0.5 μg/kg/min). Diuretic management usually involved
furosemide (1 – 10 mg/kg/day). From all patients a blood sample was
collected on the day of clinical ward admission (basal conditions). The
time-course of adiponectin in the ﬁrst month after surgery was
determined in a sub-group of 21 children (45±62 months, mean±SD,
13 males) undergone correction/pallation of CHD. Blood was collected
at different times after surgery for routinary clinical evaluation.
Informed consent was given by all parents of newborns and infants
enrolled in this study and the protocol was approved by the local ethics
committee.
Plasma adiponectin was measured by a dedicated ELISA (Linco Re-
search, St. Charles, MO, USA) previously described in detail [10]; plasma
BNP was determined using the fully automated Access platform (Access
Immunoassay Systems; Beckman Coulter, Inc., Fullerton, CA, USA).
Standard statistical analysis was carried out using the SPSS 16.0
for Mac (1989–2007, SPSS Inc., Chicago, IL, USA). Because adiponectin
levels are not normally distributed, the original data were analyzed
using non-parametric tests. A 2-tailed P-valueb0.05 was considered
statistically signiﬁcant.
Results
Adiponectin values of CHD patients, divided according to age, are
reported in Fig. 1. Adiponectin levels are highest in the ﬁrst month
of life (p=0.004 newborns vs. children) with a progressive fall in
the next few years, as previously found by us in healthy children
(11). At baseline, BNP plasma levels in CHD children were 1328±535
pg/mL and showed a signiﬁcant relationshipwith circulating adiponectin
(Spearman's rho=0.628, p=0.002) (Fig. 2), as observed in healthy
children (11).
The time-course of adiponectin levels in CHD patients after sur-
gery is shown in Fig. 3. After an initial decrease in the ﬁrst 3 days
after surgery, adiponectin levels increased slowly during the follow-
ing 2 weeks, reaching a plateau value in 1 month (Fig. 3A). To avoid




















Fig. 1. Adiponectin plasma levels in CHD patients divided according to age:
≤1 month (n=8, 6 males); ≤1 year (n=5, 2 males); ≤12 years (n=12, 6 males). For
each group, median values, 5th, 25th, 75th and 95th percentiles are reported. No signiﬁ-
cant differences were found between the ≤1 year group and both ≤1 month and
≤12 years groups.after surgery, probably masking the true effects, the percent varia-
tion of adiponectin with respect to baseline as a function of the
post-surgery time has been also reported (Fig. 3B). The similar be-
havior of both the absolute and percent variations of adiponectin in
the post-surgery suggests that the adiponectin response to injury is
similar irrespective of biological differences such as the etiology of
the congenital defects.
Discussion
The results from this preliminary study indicate that adiponectin sig-
niﬁcantly decreases in the ﬁrst 3 days after surgery, with a progressive
signiﬁcant increase over the next 2 weeks (Fig. 3). This behavior,Fig. 3. Time course of adiponectin plasma levels up to 1 month after surgery: A. mean
values (±SEM) of adiponectin concentrations; B. percentage of change after surgery. No
signiﬁcant differences were found between adiponectin values at baseline and 1, 2 and
4 weeks, respectively.
1512 C. Caselli et al. / Clinical Biochemistry 45 (2012) 1510–1512although observed in a small number of patients, suggests the involve-
ment of adiponectin in themetabolic response to injury. The fall of circu-
lating adiponectin levels observed at 3 days coincides with the acute
phase, characterized by high levels of inﬂammatory markers within
72 h [1]. Thus, the up-regulation of inﬂammatory cytokines could con-
tribute to the decline of adiponectin levels through a decrease in its rate
of synthesis in adipose tissue. The glycemic response is concomitant
with this process and the lower adiponectin levels could play a part in
promoting hyperglycemia. Adiponectin levels fall in obese and diabetic
individuals as well as in subjects with coronary heart disease, due to
inhibition by the inﬂammatory process, suggesting that the lowering
of adiponectin levels may contribute to metabolic abnormalities [5].
Thus, in our setting the adiponectin could be a possible link between
the acute and glycemic phases of the metabolic response.
On the other hand, our data closely agree with the observation
that plasma adiponectin declines transiently following myocardial
ischemia–reperfusion injury [12,13]. Adiponectin accumulates in the
heart following injury largely as a result of leakage from the vascular
compartment, contributing to the decline of circulating adiponectin
levels. Furthermore, in damaged myocardial tissue, adiponectin partic-
ipates in the wound healing process by binding the extra-cellular ma-
trix, and explicates its cardioprotective properties against myocardial
reperfusion injury by the inhibition of remodeling and apoptosis in car-
diacmyocytes and ﬁbroblasts exposed to hypoxia-reoxygenation stress
[12].
At baseline, adiponectin levels are highest in the ﬁrst month of life,
with a progressive fall in the following months and years in CHD sub-
jects (Fig. 1), as previously found in healthy control subjects [11]. This
decrease as a function of the age could be associated with differences
between neonates, infants, and children in fat distribution, adipocyte
size, inﬂammation and diet [14]. Moreover, the correlation between
adiponectin and BNP at baseline suggests that BNP could contribute
to the adiponectin levels in CHD patients, conﬁrming the relation ob-
served in healthy pediatric population [11].Conclusions
Our data strongly suggest that plasma adiponectin is modiﬁed in
response to cardiac surgery. This observation, which merits further
analysis, in turn indicates that adiponectin evaluation may be useful
to better assess the immediate metabolic response to injury, a critical
issue in pediatric patients and in particular in newborns, inwhichdeter-mination of adiponectin levels could also be important in addressing
nutritional support in the postoperative period [15].
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